TY - JOUR T1 - SGLT-2 inhibitors are potential game-changers (for more than diabetes) JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 588 LP - 589 DO - 10.3949/ccjm.88b.11021 VL - 88 IS - 11 AU - Brian F. Mandell Y1 - 2021/11/01 UR - http://www.ccjm.org/content/88/11/588.abstract N2 - ER -